Promoter region ‐318 C/ T and ‐1661 A/G CTLA‐4 single nucleotide polymorphisms and type 1 diabetes in North Indians
- 3 May 2006
- journal article
- Published by Wiley in Tissue Antigens
- Vol. 67 (5) , 383-389
- https://doi.org/10.1111/j.1399-0039.2006.00595.x
Abstract
Single nucleotide polymorphisms (SNPs) of the CTLA‐4 gene have been associated with manifestation of type 1 diabetes in several populations. We assessed the association of five SNPs present in the CTLA‐4 gene [‐318C/T, ‐1661A/G and ‐1722C/T in the promoter region, +49A/G in exon 1 and CT60 in the 3′ untranslated region (UTR) region] with type 1 diabetes in North Indian subjects. Genotyping was performed in the patients (n = 130) and the healthy control (n = 180) subjects by polymerase chain reaction‐fragment length polymorphism analysis using MseI, BbvI, BstEII and NcoI restriction endonucleases for the ‐318, ‐1661, ‐1722, +49 and CT60 SNPs, respectively. The frequency of G alleles at ‐1661 locus was significantly higher in the patient group compared with the control subjects. Although the frequency of T alleles at ‐318 SNP was significantly higher in patients with type 1 diabetes compared with the controls, it did not remain significant after Bonferroni correction for the number of alleles tested. The frequencies of C/T alleles and genotypes at ‐1722C/T and G allele at +49A/G and CT60 SNPs were not significantly different between the patient and the control groups. Of the various possible haplotypes constructed using the five genetic loci tested (‐318, ‐1661, ‐1722, +49, CT60), the frequency of ‘TGTAG’ haplotype was significantly higher in the patients when compared with the controls. The results of the present study indicate that the presence of G allele at ‐1661 locus at the CTLA‐4 gene (IDDM12 locus) is associated with increased susceptibility to type 1 diabetes in North Indians, whereas A allele is protective.Keywords
This publication has 27 references indexed in Scilit:
- Genetic analysis and functional evaluation of the C/T(−318) and A/G(−1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' diseaseClinical Immunology, 2006
- SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism lociCell Research, 2005
- CBLBvariants in type 1 diabetes and their genetic interaction withCTLA4Journal of Leukocyte Biology, 2005
- CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United StatesLupus, 2004
- Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosusArthritis & Rheumatism, 2004
- Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseaseNature, 2003
- CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter regionHuman Genetics, 2002
- CTLA-4 gene expression is influenced by promoter and exon 1 polymorphismsGenes & Immunity, 2001
- Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groupsHuman Molecular Genetics, 1997
- CTLA-4 ligation blocks CD28-dependent T cell activation.The Journal of Experimental Medicine, 1996